Related references
Note: Only part of the references are listed.Out-of-synch and out-of-sorts: Dysfunction of motor-sensory communication in schizophrenia
Judith M. Ford et al.
BIOLOGICAL PSYCHIATRY (2008)
Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings
Robyn A. Honea et al.
BIOLOGICAL PSYCHIATRY (2008)
Unaffected family members and schizophrenia patients share brain structure patterns: A high-dimensional pattern classification study
Yong Fan et al.
BIOLOGICAL PSYCHIATRY (2008)
Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review
Stephane Potvin et al.
BIOLOGICAL PSYCHIATRY (2008)
Neurophysiological biomarkers for drug development in schizophrenia
Daniel C. Javitt et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Less unique variance than meets the eye: Overlap among traditional neuropsychological dimensions in schizophrenia
Dwight Dickinson et al.
SCHIZOPHRENIA BULLETIN (2008)
Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia
Philip R. Szeszko et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
Amy Fleischman et al.
DIABETES CARE (2008)
Disturbed structural connectivity in schizophrenia - Primary factor in pathology or epiphenomenon?
Andreas Konrad et al.
SCHIZOPHRENIA BULLETIN (2008)
Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory
Hao-Yang Tan et al.
JOURNAL OF NEUROSCIENCE (2007)
The orexins/hypocretins and schizophrenia
Ariel Y. Deutch et al.
SCHIZOPHRENIA BULLETIN (2007)
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia - Is it a practice effect?
Terry E. Goldberg et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: The CNTRICS initiative
Cameron S. Carter et al.
SCHIZOPHRENIA BULLETIN (2007)
Acetylcholinesterase inhibitors may improve myelin integrity
George Bartzokis
BIOLOGICAL PSYCHIATRY (2007)
Neural synchrony in schizophrenia: From networks to new treatments
Judith M. Ford et al.
SCHIZOPHRENIA BULLETIN (2007)
C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia
Faith Dickerson et al.
SCHIZOPHRENIA RESEARCH (2007)
Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia
T. Lencz et al.
MOLECULAR PSYCHIATRY (2007)
Regional gray matter volume abnormalities in the at risk mental state
Stefan J. Borgwardt et al.
BIOLOGICAL PSYCHIATRY (2007)
COMT Val158Met and executive control: A test of the benefit of specific deficits to translational research
Angus W. MacDonald et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2007)
Overlooking the obvious - A meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia
Dwight Dickinson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents
David I. Leitman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Brain volumes in relatives of patients with schizophrenia - A meta-analysis
Heleen B. M. Boos et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments
Pamela D. Butler et al.
BRAIN (2007)
Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism
John P. Thyfault et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Schizophrenia as a GSK-3 dysregulation disorder
Simon Lovestone et al.
TRENDS IN NEUROSCIENCES (2007)
The neuropoietic cytokine family in development, plasticity, disease and injury
Sylvian Bauer et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Impairments in frontal cortical γ synchrony and cognitive control in schizophrenia
R. Y. Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hyperinsulinemia and cognitive decline in a middle-aged cohort
Sara E. Young et al.
DIABETES CARE (2006)
Olfactory functioning in schizophrenia: Relationship to clinical, neuropsychological, and volumetric MRI measures
Paul J. Moberg et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2006)
Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers
Anna L. Marsland et al.
PSYCHOSOMATIC MEDICINE (2006)
Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia
Kelvin O. Lim et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Intact attentional control of working memory encoding in schizophrenia
James M. Gold et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2006)
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Herbert Tilg et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Cognitive dysfunction in schizophrenia -: Convergence of γ-aminobutyric acid and glutamate alterations
David A. Lewis et al.
ARCHIVES OF NEUROLOGY (2006)
Baseline neurocognitive deficits in the CATIE schizophrenia trial
Richard S. E. Keefe et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Dysfunctional long-range coordination of neural activity during Gestalt perception in schizophrenia
Peter J. Uhlhaas et al.
JOURNAL OF NEUROSCIENCE (2006)
Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia
Ren-Rong Wu et al.
PSYCHOPHARMACOLOGY (2006)
A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis
Dwight Dickinson et al.
SCHIZOPHRENIA RESEARCH (2006)
Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction
Zhong Zhao et al.
SCHIZOPHRENIA RESEARCH (2006)
Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment
D Cohen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Improving metabolic control leads to better working memory in adults with type 2 diabetes
CM Ryan et al.
DIABETES CARE (2006)
Validity and stability of performance-based estimates of premorbid educational functioning in older patients with schizophrenia
PD Harvey et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2006)
Pathophysiologically based treatment interventions in schizophrenia
David A. Lewis et al.
NATURE MEDICINE (2006)
Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression
Glenn Lawyer et al.
BMC PSYCHIATRY (2006)
Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia
Mark Walterfang et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2006)
Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: A meta-analytic review of putative endophenotypes
BE Snitz et al.
SCHIZOPHRENIA BULLETIN (2006)
Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia-ischemia in the newborn rat
S Carloni et al.
NEUROBIOLOGY OF DISEASE (2006)
Diffusion tensor imaging in schizophrenia
RAA Kanaan et al.
BIOLOGICAL PSYCHIATRY (2005)
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial and comparison with national estimates from NHANES III
JP McEvoy et al.
SCHIZOPHRENIA RESEARCH (2005)
Regional deficits in brain volume in schizophrenia: A meta-analysis of voxel-based morphometry studies
R Honea et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities
C Davatzikos et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Assessing dysfunction using refined cognitive methods
J Jonides et al.
SCHIZOPHRENIA BULLETIN (2005)
Applying new approaches from cognitive neuroscience to enhance drug development for the treatment of impaired cognition in schizophrenia
CS Carter
SCHIZOPHRENIA BULLETIN (2005)
The relationship of structural alterations to cognitive deficits in schizophrenia: A voxel-based morphometry study
E Antonova et al.
BIOLOGICAL PSYCHIATRY (2005)
Mismatch negativity in schizophrenia: a meta-analysis
D Umbricht et al.
SCHIZOPHRENIA RESEARCH (2005)
Sleep apnea is a manifestation of the metabolic syndrome
AN Vgontzas et al.
SLEEP MEDICINE REVIEWS (2005)
Clinical effects of COX-2 inhibitors on cognition in schizophrenia
N Müller et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2005)
Cortical inhibitory neurons and schizophrenia
DA Lewis et al.
NATURE REVIEWS NEUROSCIENCE (2005)
The primacy of cognition in schizophrenia
RW Heinrichs
AMERICAN PSYCHOLOGIST (2005)
Gamma synchrony in first-episode schizophrenia: A disorder of temporal connectivity?
MB Symond et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
A concordance study of three electrophysiological measures in schizophrenia
S Louchart-de la Chapelle et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Theories of schizophrenia: a genetic-inflammatory-vascular synthesis
DR Hanson et al.
BMC MEDICAL GENETICS (2005)
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
ND Woodward et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Arterial stiffness and stroke in hypertension - Therapeutic implications for stroke prevention
S Laurent et al.
CNS DRUGS (2005)
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents - A frequently sampled intravenous glucose tolerance test and minimal model analysis
DC Henderson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
General and specific cognitive deficits in schizophrenia
D Dickinson et al.
BIOLOGICAL PSYCHIATRY (2004)
Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium
NA Uranova et al.
SCHIZOPHRENIA RESEARCH (2004)
Cardiovascular fitness, cortical plasticity, and aging
SJ Colcombe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Prefrontal broadband noise, working memory, and genetic risk for schizophrenia
G Winterer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis
BR Rund et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Insulin and neurodegenerative disease: shared and specific mechanisms
S Craft et al.
LANCET NEUROLOGY (2004)
The relationship between brain structure and neurocognition in schizophrenia: a selective review
E Antonova et al.
SCHIZOPHRENIA RESEARCH (2004)
Insulin resistance and executive dysfunction in older persons
AM Abbatecola et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Identification of separable cognitive factors in schizophrenia
KH Nuechterlein et al.
SCHIZOPHRENIA RESEARCH (2004)
Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
MF Green et al.
SCHIZOPHRENIA RESEARCH (2004)
The metabolic syndrome, inflammation, and risk of cognitive decline
K Yaffe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Genes, dopamine and cortical signal-to-noise ratio in schizophrenia
G Winterer et al.
TRENDS IN NEUROSCIENCES (2004)
A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: Opening a closed book
AL Mishara et al.
BIOLOGICAL PSYCHIATRY (2004)
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder
GM Simpson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
A six-factor model of cognition in schizophrenia and related psychotic disorders: Relationships with clinical symptoms and functional capacity
JA Gladsjo et al.
SCHIZOPHRENIA BULLETIN (2004)
Meta-analysis of P300 and schizophrenia: Patients, paradigms, and practical implications
YW Jeon et al.
PSYCHOPHYSIOLOGY (2003)
Executive subprocesses in working memory -: Relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia
TE Goldberg et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Inflammatory markers and cognition in well-functioning African-American and white elders
K Yaffe et al.
NEUROLOGY (2003)
Glucose effects on cognition in schizophrenia
WS Stone et al.
SCHIZOPHRENIA RESEARCH (2003)
White matter changes in schizophrenia - Evidence for myelin-related dysfunction
KL Davis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications
SP Mahadik et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2003)
Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia
MCM Ryan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Longitudinal study of symptoms and cognitive function in chronic schizophrenia
C Hughes et al.
SCHIZOPHRENIA RESEARCH (2003)
A prospective 2-year follow-up study of neurocognitive functioning in patients with first-episode schizophrenia
M Albus et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2002)
Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptoms
M Sanfilipo et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2002)
Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology
XY Zhang et al.
SCHIZOPHRENIA RESEARCH (2002)
Cognitive experimental approaches to investigating impaired cognition in schizophrenia: A paradigm shift
AW MacDonald et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2002)
Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia
PR Hof et al.
NEUROCHEMICAL RESEARCH (2002)
Olanzapine-associated diabetes mellitus
EA Koller et al.
PHARMACOTHERAPY (2002)
The neurocognitive effects of low-dose haloperidol: A two-year comparison with risperidone
MF Green et al.
BIOLOGICAL PSYCHIATRY (2002)
Factor structure of the Wechsler Adult Intelligence Scale-III in schizophrenia
D Dickinson et al.
ASSESSMENT (2002)
Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: The Rotterdam study
AE Hak et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: A comparison with Alzheimer's disease and normal aging
JI Friedman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Electron microscopy of oligodendroglia in severe mental illness
N Uranova et al.
BRAIN RESEARCH BULLETIN (2001)
Relative risk for cognitive impairments in siblings of patients with schizophrenia
MF Egan et al.
BIOLOGICAL PSYCHIATRY (2001)
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia
Y Hakak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Human intelligence differences: a recent history
IJ Deary
TRENDS IN COGNITIVE SCIENCES (2001)
Immediate effects of risperidone on cortico-striato-thalamic loops and the hippocampus
PF Liddle et al.
BRITISH JOURNAL OF PSYCHIATRY (2000)
Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: The New York high-risk project
L Erlenmeyer-Kimling et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Schizophrenia as a disorder of developmentally reduced synaptic connectivity
TH McGlashan et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates
RM Bilder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the right stuff?
MF Green et al.
SCHIZOPHRENIA BULLETIN (2000)
Share Paper
